
    
      This is a prospective, randomized, open-label study. The pioglitazone treatment group
      received 30mg pioglitazone at 2 weeks after renal transplantation for 12 months.

      After treatment, we estimated insulin sensitivity index for transplantation,first phase and
      second phase insulin secretion, secretion area under the curve,and carotid intima-media
      thickness.
    
  